The ABCR gene encodes a rod photoreceptor specific ATP-binding cassette transporter. Mutations in ABCR are associated with at least four inherited retinal dystrophies: Stargardt disease, Fundus Flavimaculatus, cone-rod dystrophy, and retinitis pigmentosa. A statistically significant increase in heterozygous ABCR alterations has been identified in patients with age-related macular degeneration (AMD). A pedigree is described which manifests both Stargardt disease and AMD in which an ABCR mutation cosegregates with both disease phenotypes. These data from this case report support the hypothesis that ABCR is a dominant susceptibility locus for AMD. Recent work regarding ABCR is reviewed and a model is presented in which decreased ABCR function correlates with severity of retinal disease.
Introduction
Age-related macular degeneration (AMD) is the leading cause of blindness in North America and Europe, affecting over 25% of individuals over the age of 75 (Bird, Bressler, Bressler, Chisholm, Coscas, Davis et al., 1995) . AMD is a complex disorder which is usually divided into two clinical categories: (1) exudative or ''wet'' AMD, characterized by drusen and subsequent invasion of the retina by blood vessels from the choroid and/or hemorrhagic detachment of the retina and retinal pigment epithelium (RPE); and (2) atrophic or ''dry'' AMD, characterized by accumulation of drusen in and under the RPE and sequential atrophy of the macular retina and RPE (Bird et al., 1995) . Environmental risk factors, including smoking and a high fat diet, have been associated with AMD (Seddon, Ajani, Sperduto, Hiller, Blair, Burton et al., 1994; Mares-Perlman, Brady, Klein, VandenLangenberg, Klein & Palta, 1995; Christen, Glynn, Manson, Ajani & Buring, 1996; Seddon, Willett, Speizer & Hankinson, 1996; Delcourt, Diaz, Ponton-Sanchez & Papoz, 1998) . However, these are not sufficient to explain the high prevalence of AMD.
Genetics of AMD
Many studies demonstrate a genetic component of age-related macular degeneration. The risk for developing AMD is at least two times higher if an individual has a first degree relative with AMD (Seddon, Ajani & Mitchell, 1997; Klaver, Wolfs, Assink, van Duijn, Hofman & de Jong, 1998) . Concordance of the AMD phenotype among monozygotic twins is 100% versus 42% among dizygotic twins (Meyers, Greene & Gutman, 1995) . However, the paucity of multigenerational affected families, the late onset of AMD, and the difficulty of strict definitional phenotypic criteria for enrollment have hampered identification of causative genes.
Single gene disorders as models for multifactorial disorders
Multifactorial disorders are complex diseases that have many environmental and genetic causes. One approach to identify genes involved in multifactorial disorders is to study simple ''model diseases'' which share phenotypic characteristics but have a clear genetic basis. An early example of an association between a monogenic disorder and a multifactorial disease was familial hypercholesterolemia. Homozygotes for mutations in the LDL receptor (LDLR) develop extremely high serum LDL levels and typically die of myocardial infarction as young adults. Heterozygotes develop moderately high LDL levels and manifest coronary artery disease in their fourth or fifth decade (Goldstein & Brown, 1973) . Wolfram syndrome (WFS) is an autosomal recessive disorder characterized by diabetes insipidus, diabetes mellitus, optic atrophy, deafness and psychiatric disorders; 60% of patients experience depression, psychosis or other psychiatric disturbance. Carriers for WFS exhibit a 26-fold risk for psychiatric institutionalization (Swift, Polymeropoulos, Torres & Swift, 1998) . Another monogenic disorder, ataxiatelangiectasia (AT), is characterized by cerebellar ataxia, telangiectases of the skin, immune dysfunction, and tumor predisposition. Heterozygous carriers of mutations in ATM, the gene for AT, have an estimated relative risk of 5.1 to develop breast cancer (Athma, Rappaport & Swift, 1996) . A common recessive disorder, cystic fibrosis is characterized primarily by pulmonary infection, meconeum ileus, and pancreatic insufficiency. Individuals heterozygous for mutations in CFTR, possibly the best studied eukaryotic ABC transporter gene, show an increased prevalence of chronic pancreatitis (Cohn, Friedman, Noone, Knowles, Silverman & Jowell, 1998; Sharer, Schwarz, Malone, Howarth, Painter, Super et al., 1998) . In each of these examples, heterozygous mutations in the causative gene predispose the carrier to development of a multifactorial disease, whereas homozygous or compound heterozygous mutations in the same gene cause a clearly recessive disorder, usually with an earlier onset and more severe and definitive clinical phenotype.
Inherited retinal dystrophies
Many inherited retinal dystrophies with a phenotype similar to AMD have been described. These include Best macular dystrophy (OMIM c153700), Sorsby fundus dystrophy (SFD; OMIM c 136900), and autosomal dominant radial drusen (Malattia Leventinese/ Doyne honeycomb retinal dystrophy; OMIM c 126600). Cloning of the SFD gene, TIMP3, allowed testing of its association with AMD. A role for TIMP3 in AMD was excluded by both mutational and linkage analysis (De La Paz, Pericak-Vance, Lennon, Haines & Felbor, Doepner, Schneider, Zrenner & Weber, 1997) .
Stargardt disease (STGD) is a juvenile onset recessive macular dystrophy which is phenotypically similar to AMD. STGD is characterized by accumulation of pisciform flecks in the mid-peripheral RPE, progressive atrophy of the central retina and RPE, temporal atrophy of the optic disk, and dark choroid on fluorescein angiography (Stargardt, 1909; Gelisken & De Laey, 1985; Armstrong, Meyer, Xu & Elfervig, 1998) . Linkage studies and analysis of recombinants defined a 2cM STGD1 locus on 1p13-p21 (Kaplan, Gerber, LargetPiet, Rozet, Dollfus, Dufier et al., 1993; Anderson, Baird, Lewis, Chinault, Otterud, Leppert et al., 1995; Hoyng, Poppelaars, van de Pol, Kremer, Pinckers, Deutman et al., 1996) . A clinically similar disorder, Fundus Flavimaculatus (FFM), was mapped to the STGD1 locus, suggesting that these two disorders are allelic (Anderson et al., 1995; Gerber, Rozet, Bonneau, Souied, Camuzat, Dufier et al., 1995) . Subsequently, a gene encoding a retina-specific ATP-binding cassette transporter (ABCR) was mapped to the STGD1 locus and mutations were identified in STGD patients (Allikmets, Singh, Sun, Shroyer, Hutchinson, Chidambaram et al., 1997b) .
ABCR in retinal disease
The ABCR gene contains 50 exons encoding an 8 kb mRNA transcript with a 6814 bp open reading frame (Allikmets et al., 1997b; Allikmets, Wasserman, Hutchinson, Smallwood, Nathans, Rogan et al., 1998; Azarian, Megarity, Weng, Horvath & Travis, 1998; Gerber, Rozet, van de Pol, Hoyng, Munnich, Blankenagel et al., 1998) . The ABCR protein is identical to rim protein (RmP), a 220 kDa protein first purified from photoreceptor outer segments (Papermaster, Converse & Zorn, 1976) , based on nucleotide and amino acid sequence identity and cross-reactivity of antibodies raised to each protein (Azarian & Travis, 1997; Illing, Molday & Molday, 1997; Sun & Nathans, 1997) . Immunohistochemical studies localize ABCR/RmP exclusively to the edge of the disk membranes of the rod photoreceptor outer segments (Papermaster, Schneider, Zorn & Kraehenbuhl, 1978; Sun & Nathans, 1997) , where it is phosphorylated in response to light (Szuts, 1985) . Recent data suggest that mice homozygous for a null allele of ABCR show a delayed recovery after photobleaching . Together, these studies suggest a role for ABCR/RmP in the photoresponse, possibly as a transporter of 11-cis retinal or other vitamin A derivatives (Sun, Molday & Nathans, 1999) .
ABCR mutations in Stargardt disease
A screen for ABCR alterations in 48 unrelated STGD patients identified 28 mutations in 22 patients, including two homozygotes and four compound heterozygotes (Allikmets et al., 1997b) . This study was recently extended to include 150 STGD families screened for all 50 exons of ABCR (Lewis, Shroyer, Singh, Allikmets, Hutchinson, Li et al., 1999) . In this latter analysis, 183 mutations were identified in 118 patients including three homozygotes and 50 compound heterozygotes. These data indicate a 57% mutation detection rate (173 alleles/302 disease chromosomes). Truncating and missense mutations in the amino terminal portion of the gene were associated with early onset disease. In ten families (7%) two mutations occurred on a single chromosome, thus resulting in several complex alleles. Another study of 55 patients with STGD/FFM identified 35 mutations in 26 patients (Rozet, Gerber, Souied, Perrault, Chatelin, Ghazi et al., 1998) . Severe mutations were associated with STGD, while milder alterations were associated with later onset FFM. These two reports suggest that severe mutations cause early onset disease. Other investigations identified 11 mutations in 8 STGD patients Nasonkin, Illing, Koehler, Schmid, Molday & Weber, 1998) . In total, these studies describe 109 distinct disease associated alleles and demonstrate the wide heterogeneity of mutations in the ABCR gene. Of the 64 patients in whom both mutations were identified (Allikmets et al., 1997b; Gerber et al., 1998; Nasonkin et al., 1998; Rozet et al., 1998; Lewis et al., 1999) , none had two obvious null mutations, suggesting that STGD patients retain some ABCR activity. These findings demonstrate that compound heterozygous or homozygous mutations in ABCR can cause STGD.
ABCR mutations in AMD
Based on the similar clinical phenotype of STGD and AMD, including macular degeneration and accumulation of pigmented material in the RPE, it was hypothesized that ABCR alterations may play a role in AMD. This hypothesis was investigated initially by screening for ABCR alterations in 167 unrelated patients with sporadic AMD (Allikmets, Shroyer, Singh, Seddon, Lewis, Bernstein et al., 1997a) . The patient cohort included 71 patients from Utah and 96 patients from the Boston area. Heteroduplex and SSCP analysis followed by DNA sequencing were used to identify ABCR alterations in 16% (26/167) of patients, primarily those with atrophic AMD. Of the 13 mutant alleles identified in patients with AMD, seven have been described in STGD patients, suggesting a pathogenic role for these alterations. The two most common AMD-associated mutations have similar frequencies in the Utah and Boston cohorts: D2177N was identified in five patients from Utah and two patients from Boston; G1961E was identified in two patients from Utah and four patients from Boston. These data show similar mutation frequencies in these two patient cohorts and suggest that these findings are not unique to a genetic isolate but are applicable generally. The control population consisted of 220 North American Caucasians ethnically matched to the AMD patients. Initially, heteroduplex and SSCP were used to screen the control population for variants in those exons in which AMD-associated ABCR mutations were found. Subsequently, this screen was extended to include all 50 exons of ABCR (Dean, Allimets, Shroyer, Lupski, Lewis, Leppert et al., 1998) . The screen of all 50 exons allows statistical analysis of the aggregate data, which shows a significant association between ABCR mutations and AMD . From this association of ABCR mutations with AMD, it was concluded that some heterozygous ABCR mutations may predispose to AMD. The interpretation of these data has been subject to controversy Dryja, Briggs, Berson, Rosenfeld, Abitbol, Klaver et al., 1998) ; further analysis is required to determine the portion of atrophic AMD which is associated with ABCR mutations.
ABCR mutations in families with STGD and AMD
Another approach to investigate the role of ABCR in AMD is to ascertain families that manifest both STGD and AMD and determine whether ABCR alterations cosegregate with both diseases. STGD families with AMD-affected relatives have been reported Lewis et al., 1999) . Identification of the underlying ABCR mutations will allow segregation analysis of these alterations within the families. Cosegregation of STGD mutations in AMD relatives would further support the association between AMD and ABCR alterations. Here we present a family which exemplifies this approach.
2.2.1.1. Patients. We have completed mutation analysis in one family, AR534, which manifests both STGD and AMD (Fig. 1) . The proband, AR534-05, presented with central visual impairment at age 11. Ophthalmoscopic inspection revealed retinal atrophy of the macula and a few peripheral flecks (Fig. 2B) . A dark choroid was observed on fluorescein angiography, and the diagnosis of STGD was made. Three paternal cousins are affected with STGD, with onset between the ages of 8 and 10. The proband's parents reported no visual impairment, but the paternal grandmother had been diagnosed previously with age-related macular degeneration at age 68 (Fig. 2C) . Subsequently, she developed hemorrhagic detachment of the macula, and a diagnosis of exudative AMD was made at age 74 (Fig. 2D) . All diagnoses were confirmed by review of clinical records including color fundus photography and fluorescein angiography.
2.2.1.2. Methods. Direct DNA sequencing of the 50 exons and flanking intronic regions of ABCR was performed as described (Allikmets et al., 1997a) . Heteroduplex analysis was performed as described (Allikmets et al., 1997a) . MspI (New England Biolabs, Inc., Beverly, MA, USA) restriction digestion was performed on PCR products according to manufacturer's recommendations.
2.2.1.3. Results. Direct DNA sequencing of all 50 exons of ABCR was performed in the proband (− 05), grandmother (−07), and a STGD-affected paternal cousin (− 10). A summary of the results is shown as Table 1 . Cosegregation of a mutant ABCR allele, P1380L, was observed with both disease phenotypes (Fig. 1) . Mutations in ABCR exons 16 and 28 were identified in AR534-05, and mutations in ABCR exons 23 and 28 were identified in AR534-10 and -12 (Fig. 1) . In addition, three polymorphisms were observed (Table 1) . Direct sequencing of these exons in all available family members showed concordant mutations in the parents of the affected individuals and in the grandparents AR534-07 and -13 (Fig. 1) .
The proband AR534-05 had two independent allelic mutations: a 4139C T transition which by conceptual translation results in the missense amino acid substitution of leucine for proline at codon 1380 (P1380L ; Fig.  1) ; and a 2461T A transversion, resulting in a predicted amino acid substitution of arginine for tryptophan at codon 821 (W821R; Fig. 1 ). The proband's affected paternal cousins AR534-10 and AR534-12 were each compound heterozygotes for two transition mutations, one (P1380L; Fig. 1 ) inherited from their mother, the other 3364G A, resulting in a predicted amino acid substitution of lysine for glutamate at codon 1122 (E1122K; Fig. 1 ), inherited from their father. Each base alteration could also be detected by heteroduplex analysis and segregated as expected (data not shown). The grandmother AR534-07 with AMD shared the P1380L mutation ( Fig. 1) but had only polymorphisms in her other ABCR allele, confirming her heterozygous state. None of these disease-associated ABCR alterations has been previously identified in our cohort of patients with AMD. However, the mutation P1380L has been seen in three unrelated STGD pedigrees (Lewis et al., 1999) .
To assess disease-association of these ABCR base alterations, DNA samples from 220 population controls were screened for variations in exons 16, 23, and 28 by heteroduplex analysis (data not shown). To investigate further the frequency of the P1380L allele, which is due to a base change that eliminates an MspI recognition site, 80 ophthalmoscopically normal individuals over the age of 65 were screened for this alteration by MspI digestion of PCR products encompassing exon 28 (data not shown). No alterations were identified in any of these 600 control chromosomes.
Together with the results of Rozet et al., who report cosegregation of ABCR mutations in two AMD affected grandmothers of STGD patients, these results support the hypothesis that some heterozygous ABCR mutations may predispose to AMD (Allikmets et al., 1997a; Rozet et al., 1998) . These findings further suggest that some carrier relatives of STGD patients may have an increased risk to develop AMD.
ABCR and other retinal disease phenotypes
Recently, homozygous null mutations in ABCR have been observed in two consanguineous pedigrees that manifest autosomal recessive retinitis pigmentosa (RP19) (Cremers, van de Pol, van Driel, den Hollander, van Haren, Knoers et al., 1998 ; Martinez-Mir, Paloma, Allikmets, Ayuso, del Rio, Dean et al., 1998) . In one family an early frameshift mutation segregates with disease (Martinez-Mir et al., 1998) . In the second pedigree, homozygotes for a null splice mutation manifest retinitis pigmentosa; whereas, compound heterozygotes with one null allele and a presumed hypomorphic allele manifest an unusual cone-rod dystrophy, similar to STGD but with severely reduced ERG and no pigmentary changes . A third pedigree in which the STGD proband's mother and maternal uncle manifest retinitis pigmentosa has been reported (Lewis et al., 1999) . These data demonstrate that identical ABCR mutations can be associated with more than one retinal disease phenotype.
A model for ABCR activity and retinal disease
To date, ABCR mutations have been described in five disease phenotypes: retinitis pigmentosa, cone-rod dystrophy, Stargardt disease, Fundus Flavimaculatus, and age-related macular degeneration. We propose a model in which ABCR activity inversely correlates with severity of disease (Fig. 3 ). In this model, truncating and severe misfolding mutations are associated with early onset disease characterized by a primary photoreceptor loss (retinitis pigmentosa and cone-rod dystrophy) and secondary RPE defects. In patients with milder mutations, photoreceptors are spared initially, but byproducts of faulty ABCR transport lead to accumulated material in the RPE and sequential photoreceptor loss (Stargardt disease and Fundus Flavimaculatus) . Finally, ABCR-associated AMD may be due to the gradual accumulation of these same byproducts with eventual photoreceptor loss. This model, in which disease severity is inversely related to ABCR activity, predicts a potential sequence of retinal pathology. Now that molecular diagnosis prior to visual loss is possible, the order of pathological events can be examined directly in patients whose DNA alterations are characterized. 
Conclusions
We reported elsewhere that seven alterations in ABCR (R1898H, G1961E, 6519del11bp, E471K, R1129L, 5196+ 1G A, and L1970F) are associated with STGD in compound heterozygous states and with AMD in an apparent heterozygous state (Allikmets et al., 1997a; Lewis et al., 1999) . In addition, we previously showed that the most common mutant ABCR allele (G1961E) identified in a cohort of 150 families was also one of the most frequently identified disease associated ABCR alterations in a cohort of 167 AMD patients (Allikmets et al., 1997a; Lewis et al., 1999) . Moreover, association of the same ABCR mutation with both STGD and AMD suggests that some family members of STGD patients may have a higher risk of developing AMD. Here, in addition to reviewing the literature, we present a case report in which we show cosegregation of an ABCR mutation with STGD and AMD in the same family, further suggesting that STGD and AMD are both phenotypically and genetically related. Further studies are required to determine the exact risk for AMD in carriers of STGD alleles.
Recent biochemical experiments suggest that ABCR transports a key molecule in the visual cycle -retinal (Sun et al., 1999) . It is not inconceivable that altered transport of retinal over an extended time period may be involved in some cases of AMD. Further studies on large AMD cohorts are required to determine the extent to which heterozygous ABCR alleles act as a dominant susceptibility locus for AMD.
It has been observed that mutations in a single gene can have an important role in multiple clinically distinct human disorders (e.g., peripherin/RDS in retinal dystrophies (Farrar, Kenna, Jordan, KumarSingh, Humphries, Sharp et al., 1991; Kajiwara, Sandberg, Berson & Dryja, 1993; Nichols, Sheffield, Vandenburgh, Drack, Kimura & Stone, 1993; Wells, Wroblewski, Keen, Inglehearn, Jubb, Eckstein et al., 1993) ; MPZ in myelinopathies (Warner, Hilz, Appel, Killian, Kolodny, Karpati et al., 1996) ; FGFR2 in craniosynostosis syndromes (Jabs, Li, Scott, Meyers, Chen, Eccles et al., 1994; Rutland, Pulleyn, Reardon, Baraitser, Hayward, Jones et al., 1995; Wilkie, Slaney, Oldridge, Poole, Ashworth, Hockley et al., 1995; Przylepa, Paznekas, Zhang, Golabi, Bias, Bamshad et al., 1996) ). These observations of allelic affinity, in which clinically distinct disorders are caused by different mutations in the same gene, and variable expressivity, in which identical mutations may yield different phenotypes depending on the genetic background of the individuals, are emerging as common themes in medical genetics. Finally, these investigations validate the paradigm of studying rare Mendelian disorders to understand common and complex multifactorial human disorders. Fig. 3 . Phenotypes associated with ABCR mutations. At left, ABCR activity is represented by the filled triangle and depicts decreasing activity towards the top. Genotypes are denoted for both chromosomes. Null denotes mutations that lead to no functional protein products including frameshift, nonesense and some splice and missense mutations. Hypo denotes hypomorphic alleles including most missense and splice mutations and some C-terminal frameshift and nonsense mutations. WT denotes wild type or normal alleles. Arrows indicate association between genotypes and phenotypes; the bracket indicates that Stargardt disease and Fundus Flavimaculatus may be caused by either of the indicated genotypes.
